Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Down's syndrome epidemiology and risk estimation

G E Palomaki1

  • 1Foundation for Blood Research, Scarborough ME, 04074, USA.

Early Human Development
|December 30, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-trimester screening for pre-eclampsia: estimated vs measured mean arterial pressure.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2022
Same author

A flawed challenge but valid recommendation: a response to Takoudes and Hamar.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2015
Same author

Circulating cell free DNA testing: are some test failures informative?

Prenatal diagnosis·2014
Same author

Inhibin A measurement using an automated assay platform.

Prenatal diagnosis·2008
Same author

The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy.

Journal of medical screening·2004
Same author

Cystic fibrosis: selecting the prenatal screening strategy of choice.

Prenatal diagnosis·2003
Same journal

Corrigendum to "2D:4D ratio, affective lability, and impulsivity in men with cannabinoid and methamphetamine use disorders: A comparative analysis with healthy controls" [Early Hum. Dev. Volume 221:106587(2026)].

Early human development·2026
Same journal

Risk factors associated with the development of metabolic bone disease in infants admitted to the pediatric intensive care unit.

Early human development·2026
Same journal

Association of cardiac perfusion index with cerebral regional oxygen saturation and fractional tissue oxygen extraction in preterm infants.

Early human development·2026
Same journal

Long-term motor outcomes after parent-administered early physiotherapy in children born very preterm.

Early human development·2026
Same journal

Second-to-fourth digit ratio in polycythemia vera: An exploratory anthropometric comparison with secondary polycythemia and healthy controls.

Early human development·2026
Same journal

Infants who crawl while skin-to-skin in the first hour after birth are more likely to effectively breastfeed postpartum.

Early human development·2026
See all related articles

Prenatal screening for Down syndrome (a genetic condition) relies on risk estimates. Validating new screening models requires independent data to avoid overestimating performance and ensure accurate Down syndrome risk assessment.

Area of Science:

  • Medical screening
  • Genetics
  • Biostatistics

Background:

  • Prenatal screening for Down syndrome commonly uses risk estimates.
  • Current methods often modify age-associated risk using biochemical markers or fetal measurements.
  • Sophisticated mathematical techniques are needed for these modifications.

Purpose of the Study:

  • To evaluate the methodology for comparing Down syndrome screening models.
  • To address the issue of performance overestimation when models are validated on their derivation data.
  • To determine the expected gains from new or refined Down syndrome risk models.

Main Methods:

  • Direct comparison of proposed and established Down syndrome screening models.
  • Utilizing a dataset of cases and controls independent of model derivation for validation.

Related Experiment Videos

  • Assessing screening performance using likelihood ratios and risk estimates.

    • Main Results:

    • Reporting screening performance on derivation data can lead to overestimated results.
    • Independent validation is crucial for accurate assessment of screening model performance.
    • Marginal gains in screening performance are typically expected from new models.

    Conclusions:

    • New models for Down syndrome risk assessment should be rigorously validated on independent datasets.
    • Overestimation of screening performance is a significant concern in model development.
    • Direct comparison of models on unseen data is essential for reliable Down syndrome screening.